| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2012 ( Subtotal = $1,422 ) |
| | 2012 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01CA159471 | Free-Breathing Perfusion MRI of the Abdomen with Predictive Motion Correction | 001 | 1 | NIH | 9/24/2012 | $0 |
| | 2012 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01NS075155 | Defining the role of mutant IDH in glioma initiation and maintenance | 001 | 1 | NIH | 1/18/2012 | $1,422 |
|
| Issue Date FY: 2011 ( Subtotal = $287,330 ) |
| | 2011 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01NS073870 | Defining the role of BRAF in glioma initiation and maintenance | 001 | 1 | NIH | 9/28/2011 | -$397,030 |
| | 2011 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01CA159471 | Free-Breathing Perfusion MRI of the Abdomen with Predictive Motion Correction | 000 | 1 | NIH | 9/14/2011 | $278,505 |
| | 2011 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01NS075155 | Defining the role of mutant IDH in glioma initiation and maintenance | 001 | 1 | NIH | 9/28/2011 | -$388,207 |
| | 2011 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01NS075155 | Defining the role of mutant IDH in glioma initiation and maintenance | 000 | 1 | NIH | 4/21/2011 | $397,031 |
| | 2011 | 2011 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01NS073870 | Defining the role of BRAF in glioma initiation and maintenance | 000 | 1 | NIH | 8/30/2011 | $397,031 |
| | 2011 | 2010 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP002730 | CANCER EDUCATION AND OUTREACH SERVICES FOR NEVADA: A PROGRAM TO PROVIDE A VARIETY | 000 | 1 | CDC | 8/9/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $600,000 ) |
| | 2010 | 2010 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP002730 | CANCER EDUCATION AND OUTREACH SERVICES FOR NEVADA: A PROGRAM TO PROVIDE A VARIETY | 000 | 1 | CDC | 8/20/2010 | $600,000 |
| | 2010 | 2010 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP002730 | CANCER EDUCATION AND OUTREACH SERVICES FOR NEVADA: A PROGRAM TO PROVIDE A VARIETY | 001 | 1 | CDC | 9/10/2010 | $0 |
| | 2010 | 2008 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP001816 | POPULATION SCIENCES PROGRAM TO REDUCE INCIDENCE AND MORTALITY OF CANCERS IN NEVAD | 000 | 1 | CDC | 10/23/2009 | $0 |
| | 2010 | 2008 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP001816 | POPULATION SCIENCES PROGRAM TO REDUCE INCIDENCE AND MORTALITY OF CANCERS IN NEVAD | 001 | 1 | CDC | 2/26/2010 | $0 |
| | 2010 | 2008 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP001816 | POPULATION SCIENCES PROGRAM TO REDUCE INCIDENCE AND MORTALITY OF CANCERS IN NEVAD | 002 | 1 | CDC | 8/17/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $1,487,101 ) |
| | 2009 | 2009 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF16010 | HEALTH CARE AND OTHER FACILITIES | 0 | 1 | HRSA | 8/28/2009 | $377,190 |
| | 2009 | 2009 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF16013 | HEALTH CARE AND OTHER FACILITIES | 0 | 1 | HRSA | 8/28/2009 | $259,380 |
| | 2009 | 2009 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01CA121118 | A High-Throughput Model for Human Melanoma | 002 | 3 | NIH | 9/18/2009 | $513,524 |
| | 2009 | 2009 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01CA108795 | RAS PEPTIDE APTAMERS | 000 | 5 | NIH | 5/29/2009 | $337,007 |
| | 2009 | 2007 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01HL075114 | BIOSENSOR CHIP FOR VENOUS THROMBOEMBOLISM GENOTYPING | 000 | 4 | NIH | 2/3/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $623,906 ) |
| | 2008 | 2008 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | H75DP001816 | POPULATION SCIENCES PROGRAM TO REDUCE INCIDENCE AND MORTALITY OF CANCERS IN NEVAD | 000 | 1 | CDC | 8/21/2008 | $286,899 |
| | 2008 | 2008 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01CA108795 | RAS PEPTIDE APTAMERS | 000 | 4 | NIH | 6/18/2008 | $337,007 |
|
| Issue Date FY: 2007 ( Subtotal = $454,635 ) |
| | 2007 | 2007 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01HL075114 | BIOSENSOR CHIP FOR VENOUS THROMBOEMBOLISM GENOTYPING | 000 | 4 | NIH | 8/1/2007 | $320,985 |
| | 2007 | 2007 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | K08CA097185 | ROLE OF HSAL 2 IN OVARIAN CANCER | 000 | 5 | NIH | 7/20/2007 | $133,650 |
|
| Issue Date FY: 2006 ( Subtotal = $464,223 ) |
| | 2006 | 2006 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | K08CA097185 | ROLE OF HSAL 2 IN OVARIAN CANCER | 000 | 4 | NIH | 8/4/2006 | $133,650 |
| | 2006 | 2006 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01HL075114 | BIOSENSOR CHIP FOR VENOUS THROMBOEMBOLISM GENOTYPING | 000 | 3 | NIH | 8/17/2006 | $330,573 |
|
| Issue Date FY: 2005 ( Subtotal = $1,454,243 ) |
| | 2005 | 2005 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01HL075114 | BIOSENSOR CHIP FOR VENOUS THROMBOEMBOLISM GENOTYPING | 000 | 2 | NIH | 9/5/2005 | $338,528 |
| | 2005 | 2005 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF00875 | HEALTH CARE AND OTHER FACILITIES | 000 | 2 | HRSA | 9/9/2005 | $982,065 |
| | 2005 | 2005 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | K08CA097185 | ROLE OF HSAL 2 IN OVARIAN CANCER | 000 | 3 | NIH | 9/13/2005 | $133,650 |
|
| Issue Date FY: 2004 ( Subtotal = $703,453 ) |
| | 2004 | 2004 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | R01HL075114 | BIOSENSOR CHIP FOR VENOUS THROMBOEMBOLISM GENOTYPING | 000 | 1 | NIH | 9/9/2004 | $358,997 |
| | 2004 | 2004 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF00875 | HEALTH CARE AND OTHER FACILITIES | 001 | 1 | HRSA | 7/27/2004 | $344,456 |
| | 2004 | 2003 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF00875 | HEALTH CARE AND OTHER FACILITIES | 002 | 1 | HRSA | 9/3/2004 | $0 |
|
| Issue Date FY: 2003 ( Subtotal = $885,210 ) |
| | 2003 | 2003 | Nevada Cancer Institute | STE 260 | IAS VEGAS | NV | 89135 | | USA | C76HF00875 | HEALTH CARE AND OTHER FACILITIES | 000 | 1 | HRSA | 9/11/2003 | $885,210 |
|
|
